logo
episode-header-image
Mar 2024
2m 28s

Episode 895: Indications for Exogenous A...

EMERGENCY MEDICAL MINUTE
About this episode

Contributor: Travis Barlock MD

Educational Pearls:

  • There are three indications for IV albumin in the ED

  • Spontaneous bacterial peritonitis (SBP)

    • Patients with SBP develop renal failure from volume depletion

    • Albumin repletes volume stores and reduces renal impairment

    • Albumin binds inflammatory cytokines and expands plasma volume

    • Reduced all-cause mortality if IV albumin is given with antibiotics

  • Hepatorenal syndrome

    • Cirrhosis of the liver causes the release of endogenous vasodilators

    • The renin-angiotensin-aldosterone system (RAAS) fails systemically but maintains vasoconstriction at the kidneys, leading to decreased renal perfusion

    • IV albumin expands plasma volume and prevents failure of the RAAS

  • Large volume paracentesis

    • Large-volume removal may lead to circulatory dysfunction

    • IV albumin is associated with a reduced risk of paracentesis-associated circulatory dysfunction

  • There are many other FDA-approved conditions for which to use exogenous albumin but the data are conflicted about the benefits on mortality

References

1. Arroyo V, Fernandez J. Pathophysiological basis of albumin use in cirrhosis. Ann Hepatol. 2011;10(SUPPL. 1):S6-S14. doi:10.1016/s1665-2681(19)31600-x

2. Bai Z, Wang L, Wang R, et al. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials. Hepatol Int. 2022;16(6):1468-1483. doi:10.1007/s12072-022-10374-z

3. Batool S, Waheed MD, Vuthaluru K, et al. Efficacy of Intravenous Albumin for Spontaneous Bacterial Peritonitis Infection Among Patients With Cirrhosis: A Meta-Analysis of Randomized Control Trials. Cureus. 2022;14(12). doi:10.7759/cureus.33124

4. Kwok CS, Krupa L, Mahtani A, et al. Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: A systematic review and meta-analysis. Biomed Res Int. 2013;2013. doi:10.1155/2013/295153

5. Sort P, Navasa M, Arroyo V, et al. Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. N Engl J Med. 1999;341(6):403-409.

Summarized by Jorge Chalit, OMSII | Edited by Meg Joyce & Jorge Chalit

 

Up next
Mar 2025
Episode 946: Time to Defibrillation
Contributor: Aaron Lessen, MD Educational Pearls: Quick background info Cardiac arrest is when the heart stops pumping blood for any reason. This is different from a heart attack in which the heart is still working but the muscle itself is starting to die. One cause of cardiac ar ... Show More
2m 30s
Feb 2025
Episode 945: Ketorolac vs. Ibuprofen
Contributor: Ricky Dhaliwal, MD Educational Pearls:  Ketorolac and ibuprofen are NSAIDs with equivalent efficacy for pain in the emergency department Oral ibuprofen provides the same relief as intramuscular ketorolac IM ketorolac is associated with the adverse effect of a painful ... Show More
3m 30s
Feb 2025
Episode 944: Colchicine Overdose
Contributor: Aaron Lessen, MD Educational Pearls: Colchicine is most commonly used for the prevention and treatment of gout There is research investigating the anti-inflammatory and cardioprotective effects of colchicine  This drug has a narrow therapeutic index: a small margin b ... Show More
3m 19s
Recommended Episodes
Feb 2020
Episode 177.0 – Hemoptysis
An overview and management tips of hemoptysis in the ED. Hosts: Brian Gilberti, MD Audrey Bree Tse, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Hemoptysis.mp3 Download One Comment Tags: Critical Care, Pulmonary Show Notes OVERVIEW: Definition: expectoration/ co ... Show More
14m 26s
Jul 2023
S2 Episode 2: Is It Lupus Nephritis? A Path to Diagnosis and Treatment
Join experts Drs Matt Sparks and Dawn Caster as they discuss the complexities around the management of lupus nephritis. What tools do we have now? What is on the horizon? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape (https://www.m ... Show More
24m 26s
Mar 2024
Episode 194: Nitrous Oxide Toxicity
We review Nitrous Oxide Toxicity: Symptoms, diagnosis, and treatment overview Hosts: Stefanie Biondi, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Nitrous_Oxide_Toxicity.mp3 Download Leave a Comment Tags: Toxicology Show Notes Patient Case Ill ... Show More
17m 12s
Jun 2024
Episode 72: Nefecon for IgAN, The NefIgArd part B trial
The Filtrate:Joel TopfJosh WaitzmanWith Special Guest:Brad Rovin (@BradRovin) Chief of nephrology at The Ohio State University Wexner Medical Center, one of the authors of the Nefigard trial. Koyal Jain (@koyaljainMD) Program director of the GN Fellowship at University of North C ... Show More
1h 32m
Oct 2023
Episode 189: Hyperkalemia 2.0
We revisit the topic of Hyperkelamia to update our prior episode from 2015 (pre-Lokelma) Hosts: Brian Gilberti, MD Jonathan Kobles, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Hyperkalemia.mp3 Download Leave a Comment Tags: Renal Colic Show Notes Introduction B ... Show More
14m 57s
Jun 2023
S2 Episode 4: An Emerging Phenomenon: Weight Gain After Initiation of Antiretroviral Therapy in Patients With HIV
Drs Michael S. Saag and Roger Bedimo discuss weight gain after starting antiretroviral therapy, including risk factors, long-term outcomes, and patients' well-being. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/98 ... Show More
23m 39s
May 2022
207. Lipids: REDUCE-IT Versus STRENGTH Trials – EPA in Clinical Practice with Dr. Peter Toth
CardioNerds Tommy Das (Program Director of the CardioNerds Academy and cardiology fellow at Cleveland Clinic), Rick Ferraro (cardiology fellow at the Johns Hopkins Hospital), and Dr. Aliza Hussain (cardiology fellow at Baylor College Medicine) take a deep dive on the REDUCE-IT tr ... Show More
53m 59s
Dec 2022
158 - PADing Your Understanding of Peripheral Arterial Disease: A Brief Treatment Overview
In this episode, we will discuss all things peripheral arterial disease – definitions, staging, clinical presentation, risk factors, goals of therapy, and guideline-directed medication therapy recommendations including the newest evidence for the use of DOACs. Key Concepts Addres ... Show More
49m 23s
Sep 2023
S2 Episode 4: Chronic Kidney Disease: FSGS, Genetic Testing, and APOL1
Join Drs Matthew Sparks and Kirk Campbell as they dive into the murky waters of focal segmental glomerular sclerosis. How do you diagnose? How do you treat? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/vi ... Show More
27m 55s
Jun 2024
GU Oncology Highlights From ASCO24
Dr. Neeraj Agarwal and Dr. Rana McKay discuss promising studies in GU cancers featured at the 2024 ASCO Annual Meeting that highlighted improved outcomes in urothelial carcinoma, improved survival in renal cell carcinoma, and the role of ctDNA as a potential biomarker for predict ... Show More
34m 54s